1. Tuberculosis treatment outcomes in a rural area of Senegal: a decade of experience from 2010 to 2019 by StopTB Italia.
- Author
-
Riccardi N, Villa S, Giacomelli A, Diaw MM, Ndiaye M, Gning L, Robbiano M, Alagna R, Saderi L, Biagio AD, Bassetti M, Cirillo DM, Sotgiu G, Codecasa LR, Sarr M, and Besozzi G
- Subjects
- Adult, Antitubercular Agents therapeutic use, Coinfection diagnosis, Coinfection drug therapy, Coinfection epidemiology, Female, HIV Infections diagnosis, HIV Infections drug therapy, HIV Infections epidemiology, Health Knowledge, Attitudes, Practice, Humans, Male, Middle Aged, Mycobacterium tuberculosis isolation & purification, Public Policy, Senegal epidemiology, Treatment Outcome, Tuberculosis diagnosis, Tuberculosis epidemiology, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary epidemiology, Young Adult, Rural Population, Tuberculosis drug therapy
- Abstract
Background: Tuberculosis (TB) unevenly affects individuals across the globe, especially in rural areas of low-income countries. Aim of the study was to assess the impact of social protection to increase TB awareness on treatment outcomes among TB patients in a rural area of Senegal. Materials & methods: The study, conducted in Fimela district (Senegal) from 1 January 2010 to 31 December 2019 and the intervention started from 31 January 2013, includes activities to increase awareness, active case finding, active follow-up and social protection. Results: Overall, 435 subjects - mainly male and young - were included in the analysis. Among TB cases, 94% had pulmonary involvement, 87% had no previous TB history, and 6% resulted positive HIV. Improved outcome was observed once intervention began (from 71 to 91%, p < 0.001); whereas mortality decreased (from 15 to 5%; p < 0.001), especially for those HIV co-infected for whom TB mortality rate dropped from 70 to 29%. Conclusion: After beginning the cooperation program, TB treatment success increased as a result of the decline of mortality, especially in people living with HIV.
- Published
- 2021
- Full Text
- View/download PDF